Cytoprotective Research Investigacin Citoprotectora Synthetic pentadecapeptide under investigation for angiogenesis, VEGF modulation and cytoprotective properties in vitro
Standard compatibility : 10ml vials are universally compatible with standard research-grade crimped vial caps and rubber stoppers
MANDATORY DISCLAIMER: This product is used solely for in vitro experiments and cannot be: (1) Used in clinical trials involving humans, (2) Administered to humans as part of an experiment or investigation, or (3) Supplied to another party for human investigational use
It activates a biological process known as lipolysis, which refers to the breakdown of fats and other lipids
Initial Loading Dose Protocol For severe deficiency, the first dose is usually 1,000 mcg given intramuscularly
PubMed (PMID: 10482990) Manning MC, Chou DK, Murphy BM, et al